Agnieszka Pluta, Tadeusz Robak, Kamil Brzozowski, Barbara Cebula-Obrzut, Agata Majchrzak, Piotr Pluta, Anna Szmigielska-Kapłon, Olga Grzybowska-Izydorczyk, Magdalena Czemerska, Piotr Stelmach, Piotr Smolewski and Agnieszka Wierzbowska
Nakagawa et al. studied NAIP mRNA expression in BM samples from 13 healthy individuals, 9 patients with AML, 7 with acutelymphoblasticleukemia (ALL) and 8 with acute mixed linage leukemia (AMLL) by quantitative RT-PCR. They found that NAIP expression was present in all examined cases and was higher in AML, ALL, and AMLL than in healthy BM samples [ 26 ].
The present study is the first to assess the expression of NAIP protein in AML cells using cytometry. It identified NAIP expression in 98% of AML patients with a range 1–79.6%. The presence of NAIP mRNA
Mateusz Nowicki, Piotr Stelmach and Anna Szmigielska-Kapłon
mRNA degradation? The deepening mystery of microRNA function Cell Res 2012 9 1322 4 10.1038/cr.2012.80
 Fan SJ, Li HB, Cui G, et al. miRNA-149* promotes cell proliferation and suppresses apoptosis by mediating JunB in T-cell acutelymphoblasticleukemia. Leuk Res 2016;41:62–70. doi: 10.1016/j. leukres.2015.11.016. 10.1016/j.leukres.2015.11.016
Fan SJ Li HB Cui G miRNA-149* promotes cell proliferation and suppresses apoptosis by mediating JunB in T-cell acutelymphoblasticleukemia Leuk Res 2016 41 62 70 10.1016/j.leukres.2015